- Home
- DARE vs SMSI Comparison
DARE vs SMSI Comparison
Compare DARE & SMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DARE
- SMSI
- Stock Information
- Founded
- DARE N/A
- SMSI 1982
- Country
- DARE United States
- SMSI United States
- Employees
- DARE N/A
- SMSI N/A
- Industry
- DARE Biotechnology: Pharmaceutical Preparations
- SMSI Computer Software: Prepackaged Software
- Sector
- DARE Health Care
- SMSI Technology
- Exchange
- DARE Nasdaq
- SMSI Nasdaq
- Market Cap
- DARE 27.9M
- SMSI 24.7M
- IPO Year
- DARE N/A
- SMSI 1995
- Fundamental
- Price
- DARE $3.17
- SMSI $1.39
- Analyst Decision
- DARE Strong Buy
- SMSI Strong Buy
- Analyst Count
- DARE 4
- SMSI 1
- Target Price
- DARE $20.33
- SMSI $5.00
- AVG Volume (30 Days)
- DARE 25.7K
- SMSI 210.2K
- Earning Date
- DARE 03-27-2025
- SMSI 03-04-2025
- Dividend Yield
- DARE N/A
- SMSI N/A
- EPS Growth
- DARE N/A
- SMSI N/A
- EPS
- DARE N/A
- SMSI N/A
- Revenue
- DARE $1,881,316.00
- SMSI $24,178,000.00
- Revenue This Year
- DARE N/A
- SMSI N/A
- Revenue Next Year
- DARE $136.52
- SMSI $53.43
- P/E Ratio
- DARE N/A
- SMSI N/A
- Revenue Growth
- DARE 88.13
- SMSI N/A
- 52 Week Low
- DARE $2.67
- SMSI $0.52
- 52 Week High
- DARE $7.56
- SMSI $5.04
- Technical
- Relative Strength Index (RSI)
- DARE 50.64
- SMSI 52.63
- Support Level
- DARE $2.95
- SMSI $1.33
- Resistance Level
- DARE $3.31
- SMSI $1.55
- Average True Range (ATR)
- DARE 0.15
- SMSI 0.13
- MACD
- DARE 0.01
- SMSI -0.01
- Stochastic Oscillator
- DARE 61.11
- SMSI 43.48
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
About SMSI Smith Micro Software Inc.
Smith Micro Software Inc is a provider of software solutions. It develops and markets wireless solutions for wireless service providers, mobile device and chipset manufacturers, and enterprise businesses. It offers multi-platform, modular solutions such as SafePath; CommSuite; and ViewSpot. The company's only reportable segment is Wireless. Its Wireless segment sells to large wireless carriers, cable operators, and OEMs.